382460
Last Update Posted: 2011-04-15
Recruiting has ended
All Genders accepted | 18 Years + |
4000 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
The primary purpose of the study was to evaluate 4000 subjects with acute coronary syndrome by comparing pravastatin 40 mg to atorvastatin 80 mg to determine if they are clinically equivalent, and to evaluate the effectiveness of gatifloxacin therapy in reducing cardiovascular events in combination with statin therapy.
Eligibility
Relevant conditions:
Actue Coronary Syndromes
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov